Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.64 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.45 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 9/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.43 |
| ▸ | DPP4 | P27487 | 3/20 | 0.43 |
| ▸ | FAP | Q12884 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30565594 | 1.00 | GSR (0.64) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| SCHEMBL28486930 | 0.93 | — | — | |
| SCHEMBL29707222 | 0.93 | — | — | |
| SCHEMBL28486931 | 0.93 | — | — | |
| Fluoride SCHEMBL28990878 | 0.91 | GSR (0.52) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| SCHEMBL29803185 | 0.82 | — | — | |
| SCHEMBL16272838 | 0.82 | — | — | |
| Lysine SCHEMBL28127136 | 0.80 | GSR (0.83) | GSRRNPEPCPB2 | |
| SCHEMBL9915164 | 0.80 | GSR (0.70) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| SCHEMBL18691832 | 0.78 | GSR (0.67) | GSRRNPEPGNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119824104-A | Application of primer for detecting eriocheir sinensis disease resistance gene in identification of eriocheir sinensis parent disease resistance | 江苏省农业科学院宿迁农科所(宿迁市农业科学研究院) | 2025-04-15 | — | — | CN | claimed |
| CN-118240809-A | Preparation and application of Acinetobacter baumannii phage lyase LysZHSHW | 华南农业大学 | 2024-06-25 | — | — | CN | claimed |
| CN-114540385-B | Method for producing lysostaphin by using escherichia coli | 齐鲁工业大学 | 2023-06-23 | — | — | CN | claimed |
| CN-114540385-A | Method for producing lysostaphin by using escherichia coli | 齐鲁工业大学 | 2022-05-27 | — | — | CN | claimed |
| CN-119824104-A | Application of primer for detecting eriocheir sinensis disease resistance gene in identification of eriocheir sinensis parent disease resistance | 江苏省农业科学院宿迁农科所(宿迁市农业科学研究院) | 2025-04-15 | — | — | CN | disclosed |
| CN-115975048-B | Antibacterial compound preparation containing eucommia ulmoides leaf extract and application of antibacterial compound preparation in food preservation and fresh-keeping | 山东龙昌动物保健品股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-116179520-B | Lysostaphin variant and method for expressing same in probiotics and application thereof | 山东大学 | 2024-11-19 | — | — | CN | disclosed |
| CN-118240809-A | Preparation and application of Acinetobacter baumannii phage lyase LysZHSHW | 华南农业大学 | 2024-06-25 | — | — | CN | disclosed |
| CN-116064481-B | Heat-resistant recombinant lysozyme, preservative prepared from heat-resistant recombinant lysozyme, eucalyptus oil and application of preservative | 山东龙昌动物保健品股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117866108-A | Multifunctional protein molecular switch for detecting small molecular compound and target protein | 重庆医科大学附属第一医院 | 2024-04-12 | — | — | CN | disclosed |
| CN-115975992-B | Lysozyme mutant with improved enzyme activity, bile acid enzyme preparation and application | 山东龙昌动物保健品股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117551595-A | Genetically engineered bacterium for high yield of D-pantothenic acid, construction method and application | 浙江工业大学 | 2024-02-13 | — | — | CN | disclosed |
| CN-116179520-A | Lysostaphin variant and method for expressing same in probiotics and application thereof | 山东大学 | 2023-05-30 | — | — | CN | disclosed |
| US-20230159971-A1 | SPIRAMYCIN-PRODUCING STRAIN, CARRIMYCIN-PRODUCING STRAIN, CONSTRUCTION METHOD THEREFOR, USE THEREOF AND METHOD FOR INCREASING PRODUCT YIELD THEREOF | SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2023-05-25 | — | — | US | disclosed |
| CN-116064481-A | Heat-resistant recombinant lysozyme, preservative prepared from heat-resistant recombinant lysozyme, eucalyptus oil and application of preservative | 山东龙昌动物保健品有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-116064482-A | Feed additive containing eucommia ulmoides leaf extract and lysozyme mutant and application thereof | 山东龙昌动物保健品有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-115975048-A | Antibacterial compound preparation containing eucommia ulmoides leaf extract and application of antibacterial compound preparation in food preservation and fresh keeping | 山东龙昌动物保健品有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115975992-A | Lysozyme mutant with improved enzyme activity, bile acid enzyme preparation and application | 山东龙昌动物保健品有限公司 | 2023-04-18 | — | — | CN | disclosed |
| WO-2022158550-A1 | BACTERIOPHAGE INFECTING DIABETES-INDUCING BACTERIUM AND USE THEREOF | 国立研究開発法人産業技術総合研究所 | 2022-07-28 | — | — | WO | disclosed |
| CN-114540385-A | Method for producing lysostaphin by using escherichia coli | 齐鲁工业大学 | 2022-05-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159971-A1 | SPIRAMYCIN-PRODUCING STRAIN, CARRIMYCIN-PRODUCING STRAIN, CONSTRUCTION METHOD THEREFOR, USE THEREOF AND METHOD FOR INCREASING PRODUCT YIELD THEREOF | MRPS18A, MRPL21, COASY | GSR 1063/4885RNPEP 828/4885GNAI3 4816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.